Cargando…

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma

Apart from its unique histopathological appearance with rare tumor cells embedded in an inflammatory background of bystander cells, classical Hodgkin lymphoma (cHL) is characterized by an unusual activation of a broad range of signaling pathways involved in cellular activation. This includes constit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wurster, K D, Hummel, F, Richter, J, Giefing, M, Hartmann, S, Hansmann, M-L, Kreher, S, Köchert, K, Krappmann, D, Klapper, W, Hummel, M, Wenzel, S-S, Lenz, G, Janz, M, Dörken, B, Siebert, R, Mathas, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339435/ https://www.ncbi.nlm.nih.gov/pubmed/27538486 http://dx.doi.org/10.1038/leu.2016.238

Ejemplares similares

Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)
por: Wurster, Kathrin D., et al.
Publicado: (2021)

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma
por: Steininger, Anne, et al.
Publicado: (2011)

c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis
por: Mathas, Stephan, et al.
Publicado: (2004)

Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity
por: Hinz, Michael, et al.
Publicado: (2002)

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma
por: Schleussner, Nikolai, et al.
Publicado: (2018)

Hodgkin-Reed-Sternberg Cells in Classical Hodgkin Lymphoma Show Alterations of Genes Encoding the NADPH Oxidase Complex and Impaired Reactive Oxygen Species Synthesis Capacity
por: Giefing, Maciej, et al.
Publicado: (2013)

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
por: Schmitz, Roland, et al.
Publicado: (2009)

T‐cell‐derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma
por: Bein, Julia, et al.
Publicado: (2022)

An Overview of the Cytoskeleton-Associated Role of PDLIM5
por: Huang, Xiaolan, et al.
Publicado: (2020)

PDLIM1: Structure, function and implication in cancer
por: Zhou, Jian-Kang, et al.
Publicado: (2021)

Novel polymorphisms in PDLIM3 and PDLIM5 gene encoding Z‐line proteins increase risk of idiopathic dilated cardiomyopathy
por: Wang, Dongfei, et al.
Publicado: (2019)

MicroRNA signature in classical Hodgkin lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)

Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines
por: Ustaszewski, Adam, et al.
Publicado: (2023)

A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses
por: de Oliveira, Kivia A. P., et al.
Publicado: (2016)

The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2020)

Secondary association of PDLIM5 with paranoid schizophrenia in Emirati patients
por: Moselhy, Hamdy, et al.
Publicado: (2015)

PDLIM2 Suppression Inhibit Proliferation and Metastasis in Kidney Cancer
por: Yuk, Hyeong-Dong, et al.
Publicado: (2021)

PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB
por: Jodo, Aya, et al.
Publicado: (2020)

Anaplastic, T-Cell, Non-Hodgkin's Lymphoma Presenting with Haematuria
por: Blick, C., et al.
Publicado: (2008)

In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis
por: Sturm, Isrid, et al.
Publicado: (2005)

Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration
por: Zain, Mohd Aizat, et al.
Publicado: (2012)

PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis
por: Li, Liwen, et al.
Publicado: (2021)

Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
por: Qiu, Cuipeng, et al.
Publicado: (2021)

Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers
por: Verdonschot, Job A. J., et al.
Publicado: (2019)

Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
por: Goncharova, Olga, et al.
Publicado: (2019)

Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
por: Tsang, Vivian
Publicado: (2012)

Experimental Evidence for the Involvement of PDLIM5 in Mood Disorders in Hetero Knockout Mice
por: Horiuchi, Yasue, et al.
Publicado: (2013)

Exome and transcriptome sequencing identifies loss of PDLIM2 in metastatic colorectal cancers
por: Oh, Bo Young, et al.
Publicado: (2017)

Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance
por: Sun, Fan, et al.
Publicado: (2019)

Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
por: Ye, Bingyu, et al.
Publicado: (2023)

Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: an evidence-based review
por: Donato, Eva M, et al.
Publicado: (2018)

Intrasinusoidal Hodgkin Lymphoma; A Mimic of Anaplastic Large Cell Lymphoma
por: Krause, John R., et al.
Publicado: (2021)

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma
por: Chen, Robert, et al.
Publicado: (2016)

Loss of the Cytoskeletal Protein Pdlim7 Predisposes Mice to Heart Defects and Hemostatic Dysfunction
por: Krcmery, Jennifer, et al.
Publicado: (2013)

PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease
por: Qu, Zhaoxia, et al.
Publicado: (2012)

Augmented AMPK activity inhibits cell migration by phosphorylating the novel substrate Pdlim5
por: Yan, Yi, et al.
Publicado: (2015)

PDLIM4/RIL-mediated regulation of Src and malignant properties of breast cancer cells
por: Kravchenko, Dmitry Sergeevich, et al.
Publicado: (2020)

Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types
por: Zeng, Yudan, et al.
Publicado: (2022)

Is the incidence of anaplastic thyroid cancer increasing: A population based epidemiology study
por: Janz, Tyler A., et al.
Publicado: (2018)

Deregulated miRNAs Contribute to Silencing of B-Cell Specific Transcription Factors and Activation of NF-κB in Classical Hodgkin Lymphoma
por: Paczkowska, Julia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_71rhqmadukvaltkqccvep0eas2